PSA17 opens call for abstracts

Panel session at PSA16

The PSA is calling for abstracts for its flagship annual conference, PSA17

Selected abstracts will be presented as part of the “Pioneering Clinical Practice and Research” stream and/or as a poster with influential academic leaders. Prizes will be awarded for the best oral presentation and poster.

PSA National President Joe Demarte says as PSA17 is a collaboration with the Commonwealth Pharmacists Association (CPA), submitting an abstract provides a unique opportunity to network with potential collaborators and have your research presented and translated on an international stage.

“PSA17 is the ideal platform to network with pharmacists and pharmacy owners as potential subjects for research,” says Mr Demarte.

“The conference schedule features a high ratio of oral presentations, so when you submit an abstract you have a great chance to boost your profile with a wide audience.”

PSA Early Career Pharmacist (ECP) National Board Director Taren Gill says PSA17 provides an opportunity to share research and ideas in Australia, giving pharmacists the flexibility to present their research without compromising hospital, university or pharmacy staff levels.

“PSA17 provides an opportunity and platform to share research, quality improvement projects and ideas in Australia,” Ms Gill says.

The conference will be held at the newly refurbished Hyatt Regency Sydney from 28–30 July, 2017. More than 50 presenters will address the conference theme of “Leading Pharmacy Innovation”, including local and international experts.

The deadline for abstracts is midnight on Friday 26 May, and presenters will be notified on 9 June.

A limited amount of early bird tickets to the event will also be available from the PSA17 website from March 2017.

For more information and to submit your abstract, click here.

Previous NZ pill downschedule good news for women, pharmacy
Next How to cut through when talking to anti-vaxxers and anti-fluoriders

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply